Chiesi will assume ownership of Ekterly, an on-demand pill approved for hereditary angioedema.
Chiesi widens rare disease portfolio with $1.9bn KalVista buyout
Chiesi will assume ownership of Ekterly, an on-demand pill approved for hereditary angioedema.
The virus that is believed to be responsible for the deaths of three people and the illnesses of three others aboard a cruise ship over the …
Acting Attorney General Todd Blanche said Sunday that the indictment of former FBI Director James Comey did not solely result from an Instagram post depicting seashells …
States where voters bypassed officials to expand Medicaid are opting for stricter implementation of new requirements.